Details of the Drug

General Information of Drug (ID: DME2RZW)

Drug Name

211At-labelled aLAT-1

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Preclinical	[1]
------------------------------------------------------------------------------------

Drug Type

Radiopharmaceutical therapy agent

Cross-matching ID

References

1	Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov. 2020 Sep;19(9):589-608.